https://www.pharmaceutical-technology.com/news/newsproterris-and-alfama-completes-merger-to-create-carbon-monoxide-therapy-leader-5806646/
Proterris has announced the completion of its merger with Alfama, creating a dominant player in carbon monoxide (CO) therapies.
carbon monoxideproterrisalfamacompletemerger